Linifanib (ABT-869)

SKU: orb154718

Description

ABT-869 is an ATP-competitive, multi-targeted RTK inhibitor that is completely effective against all members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families.

Research Area

Product Categories/Products/Small Molecules,Product Categories/Products/Small Molecules/Inhibitors

Images & Validation

−

Item 1 of 1

Key Properties

−

CAS Number	[796967-16-3]
MW	375.405
Formula	C₂₁H₁₈FN₅O
SMILES	O=C(NC1=CC=C(C2=C3C(N)=NNC3=CC=C2)C=C1)NC4=C(C=CC(C)=C4)F

Storage & Handling

−

Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Chemical structure of Linifanib (ABT-869)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols